Physiologically active extract obtained from indigo plant polygonum tinctorium
    5.
    发明授权
    Physiologically active extract obtained from indigo plant polygonum tinctorium 失效
    从靛蓝植物um子得到的生理活性提取物

    公开(公告)号:US06524625B2

    公开(公告)日:2003-02-25

    申请号:US09339928

    申请日:1999-06-25

    IPC分类号: A65K3578

    CPC分类号: A61K36/48

    摘要: A physiologically active extract comprising an ethyl acetate-soluble ingredient of an indigo plant, which is obtainable by soaking a raw indigo plant in an organic solvent used for extraction. The ethyl acetate-soluble ingredient includes tryptanthrin, 3,5,4′-trihydroxy-6,7-methylenedioxy-flavone, kaempferol, 3,5,7,4′-tetrahydroxy-6-methoxy-flavone, gallic acid, caffeic acid, indirubin, pheophorbide a, and methylpheophorbide a.

    摘要翻译: 一种生理活性提取物,其包含靛蓝植物的乙酸乙酯可溶成分,其可通过将生靛蓝植物浸泡在用于萃取的有机溶剂中获得。 乙酸乙酯可溶成分包括色胺,3,5,4'-三羟基-6,7-亚甲二氧基黄酮,山奈酚,3,5,7,4'-四羟基-6-甲氧基黄酮,没食子酸,咖啡酸 ,靛玉红,偏硼酸a和甲基偏硼酸a。

    Process for producing 2-O-alpha-D-glucopyranosyl-L-ascorbic acid
    9.
    发明授权
    Process for producing 2-O-alpha-D-glucopyranosyl-L-ascorbic acid 有权
    制备2-O-α-D-吡喃葡萄糖基-L-抗坏血酸的方法

    公开(公告)号:US08759030B2

    公开(公告)日:2014-06-24

    申请号:US10523920

    申请日:2003-07-07

    IPC分类号: C12P19/44

    CPC分类号: C12P19/60

    摘要: The object of the present invention is to provide a method and a process for producing 2-O-α-glucopyranosyl-L-ascorbic acid where 5-O-α-glucopyranosyl-L-ascorbic acid and 6-O-α-glucopyranosyl-L-ascorbic acid are not formed or formed in such a small amount that the formation of these can nor be detected. The present invention solves the above object by providing a process for producing 2-O-α-glucopyranosyl-L-ascorbic acid comprising the steps of allowing α-isomaltosyl glucosaccharide-forming enzyme together with or without cyclomaltodextrin glucanotransferase (EC 2.4.1.19) to act on a solution comprising L-ascorbic acid and, an α-glucosyl saccharide to form 2-O-α-glucopyranosyl-L-ascorbic acid and collecting the formed 2-O-α-glucopyranosyl-L-ascorbic acid.

    摘要翻译: 本发明的目的是提供一种生产2-O-α-吡喃葡萄糖基-L-抗坏血酸的方法和方法,其中5-O-α-吡喃葡萄糖基-L-抗坏血酸和6-O-α-吡喃葡萄糖基 - L-抗坏血酸不是以这样的少量形成或形成,也可以不形成。 本发明通过提供一种生产2-O-α-吡喃葡萄糖基-L-抗坏血酸的方法来解决上述目的,其包括以下步骤:将α-异麦芽糖基葡萄糖形成酶与或不与环糊精葡聚糖转移酶(EC 2.4.1.19)一起 作用于包含L-抗坏血酸和α-葡萄糖基糖的溶液中以形成2-O-α-吡喃葡萄糖基-L-抗坏血酸并收集形成的2-O-α-吡喃葡萄糖基-L-抗坏血酸。

    EXTERNAL PREPARATION FOR SKIN
    10.
    发明申请
    EXTERNAL PREPARATION FOR SKIN 有权
    外用皮肤制剂

    公开(公告)号:US20130309188A1

    公开(公告)日:2013-11-21

    申请号:US13983231

    申请日:2012-01-31

    IPC分类号: A61K8/60 A61Q19/00 A61Q19/02

    摘要: The present invention has an object to provide an external dermal agent with a sustainable anti-wrinkle action, which has both the action of enhancing the proliferation and differentiation of keratinocytes in the skin and the action of enhancing the collagen production in the skin, and which assists the maintenance and the improvement of tissue structures and physiological functions of the epidermis and the dermis, whereby providing a remarkable skin improvement effect. The present invention solves the above abject by providing an external dermal agent containing α-D-glucopyranosyl-(1→3′)-adenosine and/or α-D-glucopyranosyl-(1→5′)-adenosine as an effective ingredient(s).

    摘要翻译: 本发明的目的是提供具有可持续的抗皱作用的外用皮肤试剂,其具有增强皮肤角质形成细胞增殖和分化的作用以及增强皮肤中胶原蛋白生成的作用,其中 有助于维持和改善表皮和真皮的组织结构和生理功能,从而提供显着的皮肤改善效果。 本发明通过提供含有α-D-吡喃葡萄糖基 - (1-> 3') - 腺苷和/或α-D-吡喃葡萄糖基 - (1-> 5') - 腺苷的外用剂作为有效的方法解决了上述缺点 配料)。